 SAN DIEGO-- BUSINESS WIRE --Tandem Diabetes Care, Inc. NASDAQ: TNDM, a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2022 results after the financial markets close on Wednesday, February 22, 2023. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time 1:30 pm Pacific Time, to discuss its fourth quarter and full year 2022 financial and operating results. 